Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Source: pharmiweb.com
Stay updated with breaking news from Imke Meyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Germany - Bayer and RTW Investments, LP today announced an equity investment into Ji Xing Pharmaceuticals Limited in the amount of USD 35 million and USD 127 million respectively. JIXING, founded...
Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil.